Bionomics (Bionomics) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Bionomics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bionomics's Free Cash Flow for the three months ended in Dec. 2023 was $0.00 Mil. Bionomics's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, Bionomics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Bionomics's current FCF Yield % is -145.98%.

The historical rank and industry rank for Bionomics's FCF Margin % or its related term are showing as below:

BNOX' s FCF Margin % Range Over the Past 10 Years
Min: -97013.64 Med: -410.07 Max: 61.7
Current: -94273.33

During the past 13 years, the highest FCF Margin % of Bionomics was 61.70%. The lowest was -97013.64%. And the median was -410.07%.

BNOX's FCF Margin % is ranked worse than
97.71% of 1047 companies
in the Biotechnology industry
Industry Median: -145.04 vs BNOX: -94273.33

Bionomics FCF Margin % Historical Data

The historical data trend for Bionomics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionomics FCF Margin % Chart

Bionomics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

-410.02

-8,437.50

-8,219.89

-95,493.33

Bionomics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Bionomics's FCF Margin %

For the Biotechnology subindustry, Bionomics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionomics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bionomics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bionomics's FCF Margin % falls into.

Bionomics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bionomics's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-14.324	/	0.015
	=	-95,493.33 %

Bionomics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0
	=	%

Bionomics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bionomics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionomics (Bionomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (NAS:BNOX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

B1N0:Germany

Address

200 Greenhill Road, Eastwood, SA, AUS, 5063

Website

https://www.bionomics.com.au

Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.